The V Foundation for Cancer Research is thrilled to extend its partnership with Dolphins Cancer Challenge. This unique collaboration between the V Foundation, Dolphins Cancer Challenge and Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, will be a $10M commitment from all three parties – $30 million total over 10 years – to fund lifesaving cancer research through the Stuart Scott Memorial Cancer Research Fund, and is the largest strategic partnership in the history of the V Foundation.
This fund addresses cancer health disparities within diverse communities as well as funding general cancer research led by scientists from underrepresented groups. Since its inception, researchers have generated over 1,300 patents and been connected to over 100 clinical trials. This partnership between the V Foundation, Dolphins Cancer Challenge and Sylvester supports the nation’s top scientists, leading to groundbreaking discoveries and improving health equity across all communities of color. It will fuel the game-changing creativity of scientists and the bold ideas they have as they work on targeted therapies and cancer treatments of the future FOR ALL.
The Dolphins Cancer Challenge is entering its 15th year and is the NFL’s largest fundraising program. The event has raised more than $75 million to fund innovative cancer research at Sylvester Comprehensive Cancer Center.
The DCC is the Miami Dolphins’ year-round effort to fight cancer. The annual run/walk/bike event had more than 6,700 participants in 2024, raising more than $12 million. Participants can either bike 13, 39, 54 or 99 miles – distances that represent the jersey numbers of Dolphins Pro Football Hall of Famers – or run or walk a 5K.
In 2020, the Miami Dolphins made a commitment to raise more than $75 million for cancer research by 2026 through the DCC and that pledge was fulfilled this past February, more than two years ahead of schedule.
DCC began in 2010 to honor former Dolphins tight end and Honor Roll member Jim Mandich, who passed away from bile duct cancer in 2011.